Three recent studies showed that this tumor is characterized by a very frequent germline and somatic inactivating mutation of the SWI/SNF chromatin-remodeling gene SMARCA4, present in 69–100% of cases with a protein loss occurring in 82–100% of cases [168,169,170]. Here, SMARCA4 is linked to neoplasm.